Target intelligence / Profile preview

Prolyl endopeptidase-like (PREPL)

Target
PREPL
Molecular classification
Enzyme, Serine peptidase (Prolyl oligopeptidase family), Hydrolase (putative, with atypical or limited activity)
01

Overview

Prolyl endopeptidase-like (PREPL) is a protein encoded by the PREPL gene and belongs to the prolyl oligopeptidase family of serine peptidases[3][1][2]. Structurally, PREPL shares significant homology with prolyl endopeptidase (PREP), featuring a β-propeller and a catalytic α/β-hydrolase domain[1][2][3]. However, unlike active family members, PREPL is thought to be catalytically inactive toward classic peptide or protein substrates, with only trace hydrolytic activity observed in experimental settings[3]. The prevailing hypothesis is that PREPL mediates cellular functions primarily through protein-protein interactions rather than direct substrate cleavage, possibly playing a regulatory role in protein complexes linked to growth and neuromuscular development[1][2][3]. Deletions or mutations in PREPL can cause congenital syndromes characterized by severe growth impairment and neuromuscular symptoms, including congenital myasthenic syndrome type 22[3]. There are currently no known approved drugs or small molecules targeting PREPL, and its value as a direct therapeutic target remains speculative.

Other names
Prolyl endopeptidase-likePREPLKIAA0436CMS22prolylendopeptidase-likeputative prolyl oligopeptidase
02

Mechanism of action

No confirmed mechanism as a drug target; biological role is likely via PPI rather than classic enzymatic activity

03

Biological functions

Protein-protein interaction (PPI)Potential role in growth regulationPossible involvement in neurodevelopment or neuromuscular function
04

Disease associations

Congenital myasthenic syndrome type 22 (CMS22)Growth impairment syndromes (due to gene deletion)Other neurological or developmental disorders
05

Safety considerations

Deletion causes severe growth impairment and neuromuscular symptoms (CMS22)Possible impact on growth and neurological development if perturbed

Beyond the preview

Go deeper on Prolyl endopeptidase-like (PREPL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prolyl endopeptidase-like (PREPL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call